Verition Fund Management’s Translational Development Acquisition Corp Warrants TDACW Stock Holding History
Bought
Maintained
Sold
Other funds holding TDACW
MF
SCM
CL
AA
PAMP
LP
LA
TCM
Verition Fund Management's TDACW Position: Q1 2026 in Review
Verition Fund Management held its Translational Development Acquisition Corp Warrants (TDACW) position steady in Q1 2026 at 447,995 shares worth $71.7K. The position accounts for ﹤0.01% of the portfolio, ranked #2080.
Verition Fund Management first reported a position in TDACW in Q1 2025 and has held it in 5 quarters since. The position peaked at $139K in Q4 2025. 32 funds tracked by Wall St. Rank hold TDACW as of Q1 2026.
- Verition Fund Management held 447,995 shares of Translational Development Acquisition Corp Warrants worth $71.7K as of Q1 2026.
- Verition Fund Management left its Translational Development Acquisition Corp Warrants share count unchanged in Q1 2026.
- Translational Development Acquisition Corp Warrants made up ﹤0.01% of Verition Fund Management's portfolio in Q1 2026, its #2080 holding.
- Verition Fund Management first reported a position in Translational Development Acquisition Corp Warrants in Q1 2025 and has held it in 5 quarters since.
- Verition Fund Management's Translational Development Acquisition Corp Warrants position peaked at $139K in Q4 2025.
- 32 funds tracked by Wall St. Rank held Translational Development Acquisition Corp Warrants as of Q1 2026.
Based on Verition Fund Management's 13F filing for Q1 2026, filed 15 May 2026.